AstraZeneca's Enhertu wins conditional approval in U.K. for breast cancer
February 16 2021 - 2:16AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
AstraZeneca (NYSE:AZN)
Historical Stock Chart
From Sep 2024 to Oct 2024
AstraZeneca (NYSE:AZN)
Historical Stock Chart
From Oct 2023 to Oct 2024